Bumetanide Injection
Product Images NDC 68083-497
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 68083-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton (Carton Label 4ml Fill)
Container (Container Label 10ml Fill)
This text describes a medication called NOC68063-497-01 that is an injection containing bumetanide, sodium chloride, ammonium acetate, buffers, and preservatives. The packaging contains 10mL and must be protected from light. Instructions for dosage are provided in the package insert. The medication is produced by Gland Pharma Limited in Hyderabad, India. It is stored between 20°C-25°C. The container closure is not made of natural rubber latex and is for RX-only use.*
Container (Container Label 4ml Fill)
This is a description of a prescription drug called Bumetanide. The National Drug Code (NDC) and prescription-only designation are given, along with information on the injection, USP. It is a 1 mg/mL solution for intravenous and intramuscular use, contained in a 4 mL single-dose vial. The injection contains Benzyl Alcohol. The recommended dosage is not given, but the container closure is made with rubber. It should be stored at room temperature (20°C-25°C, 68°F-77°F). The manufacturer listed is Ind Pharma Limited, located in Hyderabad, India.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.